DOROTHY SHEPARD: Open Payments
NPI 1811609621 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$525 in 9 payments from 7 companies in 2025. Trend: 2023 $115 · 2024 $404 · 2025 $525
Food & beverage: $525
| Company | Payments | Amount |
|---|---|---|
| Genmab U.S., Inc. | 1 | $122 |
| Novocure Inc. | 2 | $120 |
| Lilly USA, LLC | 1 | $101 |
| GENZYME CORPORATION | 1 | $101 |
| Sumitomo Pharma America, Inc. | 2 | $49 |
| SERVIER PHARMACEUTICALS LLC | 1 | $19 |
| Boston Scientific Corporation | 1 | $13 |
Products named: Epkinly, Optune Gio, SARCLISA, ORGOVYX, Voranigo, Optune Lua (NovoTTF-200T), SpaceOAR System.
Industry payments across SC — which companies pay providers there.
